Key Developments Accelerating the Bio Pharma Buffer Market Landscape
As upstream cell culture technologies advance, bioreactors are achieving higher protein yields than ever before, putting a heavy burden on downstream purification operations. The downstream process, which involves separating the target therapeutic protein from host cell proteins, nucleic acids, and other cellular debris, is highly dependent on precise chemical controls. Chromatography and...
0 Comments 0 Shares 51 Views 0 Reviews